New COVID Drug Reduces Risk Of Death By 50%

Freakin COVID has been the headline for almost two years straight now, that’s wild. Doctors have discovered a new way to help reduce the risk of people passing away after they are hospitalized by 50%. That is amazing news.

Molnupiravir is an antiviral drug that was originally developed to treat influenza. Studies have proven that COVID patients who took it while they were hospitalized are 50% more likely to fight it off and survive. The trials are still early but the results are very promising.

IMUer’s be sure to watch the video below to get more informed about Molnupiravir, be sure to leave us your feedback in the comments section, and please be sure to subscribe in the top right corner.

Learn About Molnupiravir

Source & Video: WION

Cover Photo: NPR